Kornitzer Capital Management’s Transmedics TMDX Stock Holding History

Kornitzer Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-75,006	Closed	-$11.8M	–	490
2024 Q3	$11.8M	Hold	75,006	–	–	0.22%	130
2024 Q2	$11.3M	Sell	75,006 -16,285	-18%	-$1.95M	0.21%	135
2024 Q1	$6.75M	Hold	91,291	–	–	0.12%	228
2023 Q4	$7.21M	Sell	91,291 -20,000	-18%	-$1.21M	0.14%	221
2023 Q3	$6.09M	Hold	111,291	–	–	0.13%	234
2023 Q2	$9.35M	Sell	111,291 -171,985	-61%	-$13.2M	0.18%	183
2023 Q1	$21.5M	Sell	283,276 -90,220	-24%	-$6.24M	0.43%	57
2022 Q4	$23.1M	Sell	373,496 -19,430	-5%	-$1.03M	0.47%	48
2022 Q3	$16.4M	Sell	392,926 -119,468	-23%	-$5.2M	0.35%	73
2022 Q2	$16.1M	Buy	512,394 +110	+0%	+$2.93K	0.32%	84
2022 Q1	$13.8M	Buy	512,284 +45,000	+10%	+$806K	0.23%	154
2021 Q4	$8.95M	Buy	+467,284	New	+$11.7M	0.13%	230

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kornitzer Capital Management's TMDX Position: Q4 2024 in Review

Kornitzer Capital Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 75,006 shares — an estimated $11.8M sold.

Kornitzer Capital Management first reported a position in TMDX in Q4 2021 and held it in 12 quarters. The position peaked at $23.1M in Q4 2022. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

Kornitzer Capital Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
Kornitzer Capital Management sold 75,006 Transmedics shares in Q4 2024, an estimated $11.8M.
Kornitzer Capital Management first reported a position in Transmedics in Q4 2021 and held it in 12 quarters.
Kornitzer Capital Management's Transmedics position peaked at $23.1M in Q4 2022.
315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Kornitzer Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.